Загрузка...
Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results
PURPOSE: To evaluate frequency of injections, visual and anatomical outcomes of neovascular age-related macular degeneration (nAMD) patients transitioned to intravitreal aflibercept after failure to extend treatment interval beyond 8 weeks with prior intravitreal bevacizumab or ranibizumab. METHODS:...
Сохранить в:
| Опубликовано в: : | Eye (Lond) |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565952/ https://ncbi.nlm.nih.gov/pubmed/26021870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.87 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|